Kyntox Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 05-01-2025
- Revenue 194.16%
(FY 2022)
- Profit 53.59%
(FY 2022)
- Ebitda 680.05%
(FY 2022)
- Net Worth 71.18%
(FY 2022)
- Total Assets 66.29%
(FY 2022)
About Kyntox Biotech India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Swetha Peddasetty and Gopi Kadiyala serve as directors at the Company.
- CIN/LLPIN
U24304KA2018PTC110510
- Company No.
110510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kyntox Biotech India Private Limited offer?
Kyntox Biotech India Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Kyntox Biotech India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopi Kadiyala  | Director | 26-Feb-2018 | Current |
| Swetha Peddasetty | Director | 26-Feb-2018 | Current |
Financial Performance of Kyntox Biotech India.
Kyntox Biotech India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 194.16% increase. The company also saw a substantial improvement in profitability, with a 53.59% increase in profit. The company's net worth Soared by an impressive increase of 71.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kyntox Biotech India?
Unlock access to Kyntox Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sanovida Biosciences Private LimitedActive 4 years 11 daysSwetha Peddasetty and Gopi Kadiyala are mutual person
- Amgo Therapeutics Private LimitedActive 5 years 9 months
Swetha Peddasetty and Gopi Kadiyala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Sep 2022 | ₹1.50 M | Open |
How Many Employees Work at Kyntox Biotech India?
Unlock and access historical data on people associated with Kyntox Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kyntox Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyntox Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
